Prenetics Global Ltd
Business
Prenetics Global Ltd is a consumer health company that develops and commercializes science-backed health, diagnostic and precision medicine solutions. It offers premium nutritional supplements (IM8 Health), sports nutrition distribution and supply-chain services (Europa), consumer genetic testing (CircleDNA), and precision oncology testing through ACT Genomics, while holding a minority investment in multi-cancer early detection company Insighta. Its business is organized into Consumer Health, Prevention and Diagnostics segments. Prenetics distributes products direct-to-consumer online, through Europa’s U.S. wholesale and retail channels, and via hospital and physician networks across Asia, the U.S. and other international markets.
Summary from filing dated 2025-04-30
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-39.98M |
| Total assets | $206.07M |
| Total liabilities | $49.71M |
| Stockholders' equity | — |
| Operating cash flow | — |